ASRM 2024 - Vitrolife

Part of brands:

Vitrolife group at ASRM 2024

19-23 october 2024, Denver, Colorado

Presentations from ASRM 2024

If you missed any of our presentations from our Academy Studio, we have collected them below.

Webinar: 'Improvement in blastocyst development using Embryoscope'

In this Studio presentation, Dr. Simon Phillips demonstrates how the culture of embryos in the EmbryoScope Plus Time-Lapse incubation system has lead to an increase in blastocyst utilisation rate compared with other bench top incubation systems.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Sense needle – a customer experience'

Dr. Meir Olcha shares his experience of using the Sense needle for oocyte retrieval and explains the benefits of less bleeding, pain and discomfort and the overall improvement in patient experience with this innovative and unique needle design.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Fast and Glorious – let’s discuss Ultra Fast warming and vitrification'

Hear 2 experts in the field, Dr. Juergen Liebermann and Hubert Joris talk about the practical aspects, implementation and results achieved with the use of ultra fast warming and vitrification protocols.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Successfully changing your embryo culture system to Gx media'

Switching your embryo culture system from one media to another can be a difficult decision to make. Listen how Dr. George Koustas from Columbia University successfully made this transition and explains how it can easily be achieved with continued excellent results.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Optimizing individual patient treatment?'

In this panel discussion, Prof. Carlos Simon and Prof. David Gardner talks about how individualised patient treatment is the way of the future for patients undergoing IVF.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Safety with non-humidified incubation'

Non-humidified incubation of embryos is not the same as dry incubation. Listen how Francesca Bahr explains the difference and demonstrates that the EmbryoScope Time-lapse system is a safe culture environment for embryos through its advanced technological design.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'How can you trust the quality of your culture media?'

An interesting discussion with Erik Strait and Hubert Joris from the Vitrolife Group sharing their thoughts on the testing of embryo culture media and how an appropriate Mouse Embryo Assay is still our best tool for identifying sub-optimal and toxic components.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Embryo biopsy – best practice'

Learn about the tips and tricks for optimal blastocyst biopsy as well as trouble shooting techniques by Debbie Venier, co-founder of World Embryology Skills & Training.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'iDAScore for embryo selection: First RCT confirms deep-learning AI effectiveness'

Following a multi-centre RCT on the use of iDAScore as an embryo selection tool, Prof. David Gardner from Melbourne IVF explains how the use of this system can save time 10 fold during embryo evaluation in the laboratory.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Safety and security of your patients’ gametes and embryos – panel discussion'

Dr. Bec Holmes and Dr. Tex VerMilyea talks about the importance of implementation and use of an electronic witnessing system in the IVF laboratory to ensure the safe tracking and identification of their patients’ gametes and embryos at all times during the IVF process.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Embryo Quality Control with PGT-A Plus'

Renowned genetic counselors Lauri Black and Alyssa Snider discuss how the clinical application of PGT-A can be improved by combining NGS and SNP technologies. Beyond ploidy analysis, they emphasize the importance of quality control in detecting DNA contamination and other potential sources of test discrepancies.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Advancing Carrier Screening: clinical implications, customized panels, and the need for consistency in gamete donation'

Julio Martin, Product Director for Monogenic Tests, explains the universal approach to expanded carrier screening through whole exome sequencing and its associated clinical benefits. His presentation highlights matching reports as a key strategy in a successful gamete donation program.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'Unveiling the Impact of the Endometrial Microbiome: why testing the reproductive tract microbiota is crucial in infertility treatment'

Pathogenic bacteria are present in the endometrium of 30% of infertile women. By testing the endometrial microbiome, these bacteria can be identified and effectively treated. Research by Prof. Carlos Simón’s team has demonstrated that restoring a healthy microbiome is crucial for the success of fertility treatments.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

Webinar: 'EMBRACE: what to expect from embryo viability and clinical outcomes in a niPGT-A program'

Dr. Sakkas explains that as the blastocyst develops, it actively releases DNA into the culture media, with both the quantity and quality of the DNA likely increasing between days 5 and 6. His most recent publication demonstrates that extending embryo culture to day 6 for niPGT-A screening does not compromise embryo viability or affect pregnancy outcomes, making it a safe alternative for patients who wish to avoid embryo biopsy while still pursuing chromosomal testing.

This presentation was part of Vitrolife Group live Academy Studios from ASRM 2024.

For decades of innovation, we have made a difference

Our passion and commitment to making a difference in reproductive health has never been stronger.

The Vitrolife Group has a vision with a purpose: to enable people to fulfill the dream of having a healthy baby. Together, we combine high-quality medical devices with pioneering genetic testing solutions, covering the entire reproductive-health journey. Grounded in science, our innovations provide consistent performance, workflow efficiency, and guaranteed quality. Together, we create excellence in reproductive health!

Discover our values through the voices of Vitrolife Group employees

Learn more about our products & service portfolio

Highlights at ASRM 2024

eWitness

Error preventing system. For optimise lab workflow and enhance security with reliable insights.

iDAScore

iDAScore^® is an AI-based scoring system that provides fully automated analysis of time-lapse sequences.

EmbryoCath^TM - coming soon!

Our new transfer catheter, designed for smooth, precise embryo transfers with its soft, flexible build that navigates the cervical canal and uterine cavity effortlessly. Choose between the pre-curved or straight malleable.

Introducing ultra-rapid warming of blastocysts

Now available in the US! We proudly present the Ultra RapidWarm Blast, the first FDA cleared product for ultra-fast warming in the US. Ultra RapidWarm Blast is a game-changer for the warming procedure. You maintain stable results and save 8-11 minutes per blastocyst!

VitroTemp

For accurate, easy and consistent temperature measurements of media during operations outside the incubator.

Gx Media

Gx Media is our latest addition in our media portfolio that includes triple antioxidant protection for improved embryo viability.

Do you want more information about our products?

Download brochures

Igenomix's highlights at ASRM 2024

PGT-A Plus

A new enhanced version of our PGT-A test that now also includes features such as Genetic PN check, contamination and sibling quality control.

EMBRACE

A non-invasive test for prioritizing embryo transfer that avoids invasive embryo biopsy, potentially increasing accessibility for a wider patient population.

Upgraded EMMA & ALICE

Based on more than 70.000 samples we can now detect bacteria at the species level, allowing for more targeted treatments.

niPOC

A non-invasive, tissue-independent approach for assessing the origin of early pregnancy loss, determining chromosomal abnormalities, through a simple blood test.

ERA®

Endometrial Receptivity Analysis
Maximize the chances of pregnancy without losing valuable embryos

CGT

Carrier Genetic Test
Determines the risk of having a child with a genetic disease